Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).
来源：PubMed发布日期：2026-07-17作者：Pérez-Martínez A, Cabrero M, Montoro J, Sánchez-Escamilla M, Cuesta MÁ0 次点击